

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 6.42336133 |
| 2 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 5.79590316 |
| 3 | DNA deamination (GO:0045006) | 5.36877468 |
| 4 | somite development (GO:0061053) | 5.14155917 |
| 5 | axoneme assembly (GO:0035082) | 5.08167623 |
| 6 | regulation of cilium movement (GO:0003352) | 4.99656588 |
| 7 | epithelial cilium movement (GO:0003351) | 4.79686503 |
| 8 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.76941067 |
| 9 | chemical homeostasis within a tissue (GO:0048875) | 4.76679861 |
| 10 | protein polyglutamylation (GO:0018095) | 4.69839294 |
| 11 | cilium movement (GO:0003341) | 4.64906686 |
| 12 | axonemal dynein complex assembly (GO:0070286) | 4.52236583 |
| 13 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.48572671 |
| 14 | response to pheromone (GO:0019236) | 4.24689231 |
| 15 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 4.19251873 |
| 16 | regulation of memory T cell differentiation (GO:0043380) | 4.12125547 |
| 17 | adaptation of signaling pathway (GO:0023058) | 4.02666666 |
| 18 | retinal cone cell development (GO:0046549) | 4.01777639 |
| 19 | nonmotile primary cilium assembly (GO:0035058) | 3.91014810 |
| 20 | cellular response to exogenous dsRNA (GO:0071360) | 3.90701089 |
| 21 | motile cilium assembly (GO:0044458) | 3.84694310 |
| 22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.83295201 |
| 23 | reflex (GO:0060004) | 3.60569103 |
| 24 | activated T cell proliferation (GO:0050798) | 3.50152375 |
| 25 | striatum development (GO:0021756) | 3.40887807 |
| 26 | one-carbon compound transport (GO:0019755) | 3.38699958 |
| 27 | positive T cell selection (GO:0043368) | 3.38096874 |
| 28 | regulation of vasculogenesis (GO:2001212) | 3.36526939 |
| 29 | glycosphingolipid biosynthetic process (GO:0006688) | 3.32651590 |
| 30 | cellular response to nitric oxide (GO:0071732) | 3.29990592 |
| 31 | leukotriene biosynthetic process (GO:0019370) | 3.24464992 |
| 32 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.22267517 |
| 33 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.18408132 |
| 34 | lipoxygenase pathway (GO:0019372) | 3.18196492 |
| 35 | positive regulation of defense response to virus by host (GO:0002230) | 3.17125436 |
| 36 | regulation of microtubule-based movement (GO:0060632) | 3.16255268 |
| 37 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.14674881 |
| 38 | positive regulation of T cell cytokine production (GO:0002726) | 3.14233386 |
| 39 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.13912402 |
| 40 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.13692595 |
| 41 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09078751 |
| 42 | left/right axis specification (GO:0070986) | 3.06096224 |
| 43 | cytidine deamination (GO:0009972) | 3.05170630 |
| 44 | cytidine metabolic process (GO:0046087) | 3.05170630 |
| 45 | cytidine catabolic process (GO:0006216) | 3.05170630 |
| 46 | neuronal action potential propagation (GO:0019227) | 3.04693463 |
| 47 | regulation of immunoglobulin secretion (GO:0051023) | 2.98484913 |
| 48 | kidney morphogenesis (GO:0060993) | 2.97357240 |
| 49 | rRNA modification (GO:0000154) | 2.95453806 |
| 50 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.94683951 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 2.94399037 |
| 52 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.94324899 |
| 53 | detection of light stimulus involved in visual perception (GO:0050908) | 2.94324899 |
| 54 | cellular response to interferon-beta (GO:0035458) | 2.93911162 |
| 55 | negative T cell selection (GO:0043383) | 2.92938981 |
| 56 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.90862660 |
| 57 | NAD biosynthetic process (GO:0009435) | 2.88479136 |
| 58 | urate metabolic process (GO:0046415) | 2.86296248 |
| 59 | response to gravity (GO:0009629) | 2.84694131 |
| 60 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.80324999 |
| 61 | positive regulation of vasculogenesis (GO:2001214) | 2.80301828 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 2.78715262 |
| 63 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.78136755 |
| 64 | GPI anchor metabolic process (GO:0006505) | 2.77229231 |
| 65 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.71691778 |
| 66 | negative regulation of response to food (GO:0032096) | 2.71271886 |
| 67 | negative regulation of appetite (GO:0032099) | 2.71271886 |
| 68 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.69149577 |
| 69 | valine metabolic process (GO:0006573) | 2.68838295 |
| 70 | positive regulation of phosphatase activity (GO:0010922) | 2.68159081 |
| 71 | cilium morphogenesis (GO:0060271) | 2.67340742 |
| 72 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.67034780 |
| 73 | regulation of appetite (GO:0032098) | 2.61212210 |
| 74 | respiratory gaseous exchange (GO:0007585) | 2.60780781 |
| 75 | tryptophan catabolic process (GO:0006569) | 2.58715696 |
| 76 | indole-containing compound catabolic process (GO:0042436) | 2.58715696 |
| 77 | indolalkylamine catabolic process (GO:0046218) | 2.58715696 |
| 78 | cellular response to leptin stimulus (GO:0044320) | 2.58121302 |
| 79 | response to interferon-beta (GO:0035456) | 2.57619725 |
| 80 | ATP synthesis coupled proton transport (GO:0015986) | 2.56591726 |
| 81 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.56591726 |
| 82 | sodium ion homeostasis (GO:0055078) | 2.55658141 |
| 83 | negative regulation of mast cell activation (GO:0033004) | 2.53624950 |
| 84 | cilium organization (GO:0044782) | 2.52167343 |
| 85 | glycolipid biosynthetic process (GO:0009247) | 2.51911460 |
| 86 | arachidonic acid secretion (GO:0050482) | 2.50980753 |
| 87 | icosanoid secretion (GO:0032309) | 2.50980753 |
| 88 | thalamus development (GO:0021794) | 2.49023109 |
| 89 | protein homotrimerization (GO:0070207) | 2.48381928 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 2.48308456 |
| 91 | organelle membrane fusion (GO:0090174) | 2.48223154 |
| 92 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.47828629 |
| 93 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.47492004 |
| 94 | cellular response to reactive nitrogen species (GO:1902170) | 2.47355556 |
| 95 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.47031501 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.47031501 |
| 97 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.46554862 |
| 98 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.46233088 |
| 99 | regulation of response to food (GO:0032095) | 2.42531035 |
| 100 | regulation of defense response to virus by host (GO:0050691) | 2.42493141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.49028489 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.14870392 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.17223771 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.97100594 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.74051727 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.54840058 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.53739820 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.50134634 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.40769253 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.36828241 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.08135587 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.06094213 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00142964 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.97236484 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.89621204 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89172570 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87245294 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.84198828 |
| 19 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.81027811 |
| 20 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.81027811 |
| 21 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.78582671 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77965226 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74905532 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68691376 |
| 25 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64823168 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60428633 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60023833 |
| 28 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59630764 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58358574 |
| 30 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.53118325 |
| 31 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52686014 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52255523 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50990082 |
| 34 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49469432 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48129800 |
| 36 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.48036358 |
| 37 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46705905 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41704930 |
| 39 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.37408629 |
| 40 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36513171 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.35854757 |
| 42 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.33651272 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28964965 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 1.25482665 |
| 45 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24637142 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24544784 |
| 47 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24529723 |
| 48 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.24351833 |
| 49 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.23851395 |
| 50 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23145006 |
| 51 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22292325 |
| 52 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.22178422 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22142640 |
| 54 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.21116232 |
| 55 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20685444 |
| 56 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18071412 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17804065 |
| 58 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.17479436 |
| 59 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.17479436 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16531650 |
| 61 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.15878323 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15018973 |
| 63 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.14132340 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.12763533 |
| 65 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.12529419 |
| 66 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.12529419 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12417640 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12245801 |
| 69 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.11173696 |
| 70 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10704508 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09378642 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08776045 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.08582622 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08143000 |
| 75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07925357 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06797581 |
| 77 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06545876 |
| 78 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06408790 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.06349354 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06210394 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05245272 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04244204 |
| 83 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02807042 |
| 84 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.01714248 |
| 85 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.00350656 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.99539246 |
| 87 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99327861 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.98428190 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.98303249 |
| 90 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98065733 |
| 91 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97848573 |
| 92 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.97456925 |
| 93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96601895 |
| 94 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.96487027 |
| 95 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95884996 |
| 96 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93488103 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93487198 |
| 98 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.93358610 |
| 99 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.92989205 |
| 100 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.92372263 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004782_abnormal_surfactant_physiolog | 3.70457206 |
| 2 | MP0008995_early_reproductive_senescence | 3.25335966 |
| 3 | MP0001986_abnormal_taste_sensitivity | 3.24421582 |
| 4 | MP0003950_abnormal_plasma_membrane | 2.74232957 |
| 5 | MP0001984_abnormal_olfaction | 2.64570564 |
| 6 | MP0003724_increased_susceptibility_to | 2.63939024 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.58919648 |
| 8 | MP0005671_abnormal_response_to | 2.56955530 |
| 9 | MP0005423_abnormal_somatic_nervous | 2.48570510 |
| 10 | MP0002736_abnormal_nociception_after | 2.46063915 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.25620380 |
| 12 | MP0002254_reproductive_system_inflammat | 2.22984768 |
| 13 | MP0001958_emphysema | 2.12071288 |
| 14 | MP0001486_abnormal_startle_reflex | 2.07736128 |
| 15 | MP0003195_calcinosis | 1.98064586 |
| 16 | MP0002653_abnormal_ependyma_morphology | 1.95385633 |
| 17 | MP0008058_abnormal_DNA_repair | 1.94553927 |
| 18 | MP0002102_abnormal_ear_morphology | 1.91016942 |
| 19 | MP0005646_abnormal_pituitary_gland | 1.88819576 |
| 20 | MP0005253_abnormal_eye_physiology | 1.80998020 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.76642992 |
| 22 | MP0006292_abnormal_olfactory_placode | 1.71043507 |
| 23 | MP0003436_decreased_susceptibility_to | 1.66457147 |
| 24 | MP0002234_abnormal_pharynx_morphology | 1.65488167 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.60521021 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.53560899 |
| 27 | MP0000613_abnormal_salivary_gland | 1.52247707 |
| 28 | MP0002090_abnormal_vision | 1.51751274 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.51498862 |
| 30 | MP0005084_abnormal_gallbladder_morpholo | 1.50446844 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.47553023 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.46351352 |
| 33 | MP0001440_abnormal_grooming_behavior | 1.45290444 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.45214144 |
| 35 | MP0001542_abnormal_bone_strength | 1.37036081 |
| 36 | MP0001970_abnormal_pain_threshold | 1.36681591 |
| 37 | MP0003866_abnormal_defecation | 1.34916697 |
| 38 | MP0001790_abnormal_immune_system | 1.32386360 |
| 39 | MP0005387_immune_system_phenotype | 1.32386360 |
| 40 | MP0002272_abnormal_nervous_system | 1.30047665 |
| 41 | MP0009053_abnormal_anal_canal | 1.29706171 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.26263437 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 1.21379855 |
| 44 | MP0002282_abnormal_trachea_morphology | 1.19497244 |
| 45 | MP0009785_altered_susceptibility_to | 1.19377278 |
| 46 | MP0008789_abnormal_olfactory_epithelium | 1.19267385 |
| 47 | MP0005647_abnormal_sex_gland | 1.17868155 |
| 48 | MP0003283_abnormal_digestive_organ | 1.17079859 |
| 49 | MP0008004_abnormal_stomach_pH | 1.15266487 |
| 50 | MP0004885_abnormal_endolymph | 1.15180662 |
| 51 | MP0001346_abnormal_lacrimal_gland | 1.13744469 |
| 52 | MP0005332_abnormal_amino_acid | 1.13606830 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.13352754 |
| 54 | MP0005195_abnormal_posterior_eye | 1.10615872 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.10290587 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.09337961 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.08994312 |
| 58 | MP0001529_abnormal_vocalization | 1.06630258 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.05703970 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.02933682 |
| 61 | MP0005310_abnormal_salivary_gland | 1.02589220 |
| 62 | MP0001905_abnormal_dopamine_level | 1.01732284 |
| 63 | MP0000685_abnormal_immune_system | 1.00343185 |
| 64 | MP0002095_abnormal_skin_pigmentation | 0.99309143 |
| 65 | MP0002006_tumorigenesis | 0.97630819 |
| 66 | MP0005174_abnormal_tail_pigmentation | 0.96084895 |
| 67 | MP0005388_respiratory_system_phenotype | 0.94707709 |
| 68 | MP0002133_abnormal_respiratory_system | 0.94707709 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 0.93023814 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 0.92873842 |
| 71 | MP0001853_heart_inflammation | 0.92124233 |
| 72 | MP0002557_abnormal_social/conspecific_i | 0.90600858 |
| 73 | MP0005360_urolithiasis | 0.88943920 |
| 74 | MP0004142_abnormal_muscle_tone | 0.87931185 |
| 75 | MP0009643_abnormal_urine_homeostasis | 0.87744663 |
| 76 | MP0000631_abnormal_neuroendocrine_gland | 0.87672418 |
| 77 | MP0002168_other_aberrant_phenotype | 0.87605505 |
| 78 | MP0000639_abnormal_adrenal_gland | 0.85902846 |
| 79 | MP0009046_muscle_twitch | 0.83824228 |
| 80 | MP0010329_abnormal_lipoprotein_level | 0.83292336 |
| 81 | MP0002064_seizures | 0.83066523 |
| 82 | MP0003786_premature_aging | 0.82404735 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.79018955 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.77775627 |
| 85 | MP0010368_abnormal_lymphatic_system | 0.77709630 |
| 86 | MP0003136_yellow_coat_color | 0.77264809 |
| 87 | MP0001765_abnormal_ion_homeostasis | 0.76640156 |
| 88 | MP0003878_abnormal_ear_physiology | 0.75433764 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 0.75433764 |
| 90 | MP0001293_anophthalmia | 0.75345379 |
| 91 | MP0001664_abnormal_digestion | 0.74809352 |
| 92 | MP0002405_respiratory_system_inflammati | 0.74182425 |
| 93 | MP0000427_abnormal_hair_cycle | 0.74021571 |
| 94 | MP0003045_fibrosis | 0.73049632 |
| 95 | MP0009745_abnormal_behavioral_response | 0.72179052 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.70411198 |
| 97 | MP0005000_abnormal_immune_tolerance | 0.69379125 |
| 98 | MP0002067_abnormal_sensory_capabilities | 0.68667074 |
| 99 | MP0004043_abnormal_pH_regulation | 0.68490837 |
| 100 | MP0002063_abnormal_learning/memory/cond | 0.66882664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.67321835 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 5.67321835 |
| 3 | Interstitial pulmonary disease (HP:0006530) | 4.85875574 |
| 4 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.77659139 |
| 5 | Visual hallucinations (HP:0002367) | 4.44200113 |
| 6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.43849416 |
| 7 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.21343262 |
| 8 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.21343262 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.19089805 |
| 10 | Abnormal ciliary motility (HP:0012262) | 4.14403838 |
| 11 | Chronic bronchitis (HP:0004469) | 4.09717396 |
| 12 | Prostate neoplasm (HP:0100787) | 3.85679007 |
| 13 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.70397446 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.48567685 |
| 15 | Testicular atrophy (HP:0000029) | 3.38733554 |
| 16 | Tachypnea (HP:0002789) | 3.37652154 |
| 17 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.34461304 |
| 18 | Tubulointerstitial fibrosis (HP:0005576) | 3.31142717 |
| 19 | Medial flaring of the eyebrow (HP:0010747) | 3.30973247 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.21979049 |
| 21 | Abnormality of the renal cortex (HP:0011035) | 3.17167974 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17041203 |
| 23 | Methylmalonic acidemia (HP:0002912) | 3.08354295 |
| 24 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.02411844 |
| 25 | Renal cortical cysts (HP:0000803) | 2.94605943 |
| 26 | Exertional dyspnea (HP:0002875) | 2.91426552 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 2.89169643 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 2.89169643 |
| 29 | Pancreatic cysts (HP:0001737) | 2.87014630 |
| 30 | Alveolar cell carcinoma (HP:0006519) | 2.86819351 |
| 31 | Asplenia (HP:0001746) | 2.84654962 |
| 32 | Abnormality of the prostate (HP:0008775) | 2.81512865 |
| 33 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.80763801 |
| 34 | Tubulointerstitial abnormality (HP:0001969) | 2.79927656 |
| 35 | Rhinitis (HP:0012384) | 2.78070586 |
| 36 | Congenital stationary night blindness (HP:0007642) | 2.69007751 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.67163707 |
| 38 | Nephronophthisis (HP:0000090) | 2.64238040 |
| 39 | Abolished electroretinogram (ERG) (HP:0000550) | 2.52361154 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 2.48633184 |
| 41 | Decreased circulating renin level (HP:0003351) | 2.47018922 |
| 42 | Polydipsia (HP:0001959) | 2.44044372 |
| 43 | Abnormal drinking behavior (HP:0030082) | 2.44044372 |
| 44 | True hermaphroditism (HP:0010459) | 2.42571341 |
| 45 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.41472726 |
| 46 | Tubulointerstitial nephritis (HP:0001970) | 2.31754609 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.28774609 |
| 48 | 3-Methylglutaconic aciduria (HP:0003535) | 2.26054391 |
| 49 | Bronchiectasis (HP:0002110) | 2.24106289 |
| 50 | Tubular atrophy (HP:0000092) | 2.23270653 |
| 51 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.20478117 |
| 52 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.18685934 |
| 53 | Hypoplasia of the fovea (HP:0007750) | 2.18685934 |
| 54 | Pulmonary fibrosis (HP:0002206) | 2.18033517 |
| 55 | Congenital primary aphakia (HP:0007707) | 2.14375347 |
| 56 | Hypoproteinemia (HP:0003075) | 2.13194882 |
| 57 | Focal motor seizures (HP:0011153) | 2.09889835 |
| 58 | Gait imbalance (HP:0002141) | 2.09112846 |
| 59 | Adactyly (HP:0009776) | 2.08648286 |
| 60 | Spastic diplegia (HP:0001264) | 2.07344196 |
| 61 | Respiratory distress (HP:0002098) | 2.07185064 |
| 62 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.06388275 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.06388275 |
| 64 | Bronchitis (HP:0012387) | 2.05825442 |
| 65 | Hemiparesis (HP:0001269) | 2.03073407 |
| 66 | Hyperactive renin-angiotensin system (HP:0000841) | 1.99883395 |
| 67 | Abnormality of vitamin B metabolism (HP:0004340) | 1.98456679 |
| 68 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97546368 |
| 69 | Termporal pattern (HP:0011008) | 1.96766476 |
| 70 | Insidious onset (HP:0003587) | 1.96766476 |
| 71 | Chronic hepatic failure (HP:0100626) | 1.95527703 |
| 72 | Opisthotonus (HP:0002179) | 1.90548222 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 1.87808659 |
| 74 | Panhypogammaglobulinemia (HP:0003139) | 1.87798959 |
| 75 | Acute necrotizing encephalopathy (HP:0006965) | 1.86338461 |
| 76 | Methylmalonic aciduria (HP:0012120) | 1.84732687 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 1.84054436 |
| 78 | Abnormality of the fovea (HP:0000493) | 1.82043098 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 1.81982050 |
| 80 | Abnormal number of erythroid precursors (HP:0012131) | 1.81937056 |
| 81 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.81879231 |
| 82 | Central scotoma (HP:0000603) | 1.81768713 |
| 83 | Renal salt wasting (HP:0000127) | 1.80949614 |
| 84 | Polyuria (HP:0000103) | 1.78478495 |
| 85 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78132692 |
| 86 | Abnormality of alanine metabolism (HP:0010916) | 1.78132692 |
| 87 | Hyperalaninemia (HP:0003348) | 1.78132692 |
| 88 | Abnormality of the fingertips (HP:0001211) | 1.77182007 |
| 89 | Parakeratosis (HP:0001036) | 1.76569526 |
| 90 | Cystic liver disease (HP:0006706) | 1.76508891 |
| 91 | Constricted visual fields (HP:0001133) | 1.73831081 |
| 92 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72253111 |
| 93 | Thyroiditis (HP:0100646) | 1.72073101 |
| 94 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.70250600 |
| 95 | Dyschromatopsia (HP:0007641) | 1.67596447 |
| 96 | Papilledema (HP:0001085) | 1.67205757 |
| 97 | Abnormality of T cell physiology (HP:0011840) | 1.66954163 |
| 98 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.66363731 |
| 99 | Pheochromocytoma (HP:0002666) | 1.65138843 |
| 100 | Optic disc pallor (HP:0000543) | 1.61992330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.44856476 |
| 2 | FRK | 3.79115019 |
| 3 | MAP4K2 | 3.34373412 |
| 4 | TLK1 | 3.21250059 |
| 5 | EPHA3 | 3.06151955 |
| 6 | MST4 | 2.57044401 |
| 7 | TIE1 | 2.03003876 |
| 8 | DAPK2 | 2.01380563 |
| 9 | PINK1 | 2.00625582 |
| 10 | MAP4K1 | 1.75569129 |
| 11 | MKNK1 | 1.75445673 |
| 12 | MAPK15 | 1.64652419 |
| 13 | FES | 1.55113979 |
| 14 | GRK1 | 1.53008568 |
| 15 | NEK1 | 1.52829261 |
| 16 | EPHB2 | 1.51796332 |
| 17 | PKN2 | 1.51319260 |
| 18 | AKT3 | 1.49922010 |
| 19 | BMPR2 | 1.49718973 |
| 20 | ADRBK2 | 1.47442508 |
| 21 | BCKDK | 1.45471867 |
| 22 | MAPKAPK3 | 1.43312368 |
| 23 | NUAK1 | 1.37515725 |
| 24 | MYLK | 1.36419520 |
| 25 | ZAK | 1.35307933 |
| 26 | WNK3 | 1.32939143 |
| 27 | TAOK3 | 1.28434726 |
| 28 | IKBKB | 1.20847893 |
| 29 | RPS6KA5 | 1.19411636 |
| 30 | WEE1 | 1.12246179 |
| 31 | JAK1 | 1.11244607 |
| 32 | BMPR1B | 1.10256742 |
| 33 | MAPK13 | 1.05094731 |
| 34 | STK24 | 1.04098917 |
| 35 | PNCK | 1.01367020 |
| 36 | GRK7 | 0.93234616 |
| 37 | PAK3 | 0.92513546 |
| 38 | PIK3CA | 0.92396074 |
| 39 | MAPKAPK5 | 0.91983676 |
| 40 | DAPK1 | 0.89533705 |
| 41 | CASK | 0.89483819 |
| 42 | PRKCG | 0.85980389 |
| 43 | INSRR | 0.85894511 |
| 44 | CAMK2A | 0.85055252 |
| 45 | CSNK1A1L | 0.84901883 |
| 46 | TBK1 | 0.81473200 |
| 47 | PRKCQ | 0.80294198 |
| 48 | ZAP70 | 0.80041622 |
| 49 | WNK4 | 0.79061993 |
| 50 | KIT | 0.78236029 |
| 51 | FLT3 | 0.77107827 |
| 52 | GRK5 | 0.76901704 |
| 53 | CHUK | 0.76800039 |
| 54 | CAMK2G | 0.74245789 |
| 55 | PRKCE | 0.73752828 |
| 56 | SRPK1 | 0.70910574 |
| 57 | TGFBR1 | 0.69055742 |
| 58 | ERBB2 | 0.68483519 |
| 59 | TRIM28 | 0.66164072 |
| 60 | LYN | 0.65772000 |
| 61 | STK38L | 0.64603530 |
| 62 | CAMK2D | 0.63040020 |
| 63 | CSNK1G3 | 0.59418396 |
| 64 | CSNK1G2 | 0.58893756 |
| 65 | LRRK2 | 0.58034681 |
| 66 | CAMKK2 | 0.57463743 |
| 67 | ADRBK1 | 0.56619769 |
| 68 | PTK2B | 0.56238573 |
| 69 | TGFBR2 | 0.55810579 |
| 70 | BCR | 0.54720903 |
| 71 | JAK2 | 0.54306998 |
| 72 | TNK2 | 0.53559259 |
| 73 | PRKCA | 0.53289823 |
| 74 | DYRK2 | 0.53091838 |
| 75 | SYK | 0.51974067 |
| 76 | PRKACA | 0.51856299 |
| 77 | MAP3K12 | 0.51224725 |
| 78 | PRKCI | 0.50028146 |
| 79 | CSNK1G1 | 0.49874520 |
| 80 | NME2 | 0.49194700 |
| 81 | STK16 | 0.48691570 |
| 82 | KDR | 0.48264370 |
| 83 | PRKACB | 0.47330187 |
| 84 | IGF1R | 0.46350778 |
| 85 | FER | 0.46104687 |
| 86 | IRAK1 | 0.44324400 |
| 87 | CSNK2A1 | 0.44269217 |
| 88 | ERBB3 | 0.44194831 |
| 89 | SGK2 | 0.43854221 |
| 90 | SGK1 | 0.41969344 |
| 91 | BRSK2 | 0.41604329 |
| 92 | EGFR | 0.41526862 |
| 93 | CSNK1A1 | 0.40714916 |
| 94 | AURKA | 0.40552838 |
| 95 | MAPK7 | 0.40265789 |
| 96 | GSK3A | 0.39696938 |
| 97 | TEC | 0.38456461 |
| 98 | SRC | 0.37731703 |
| 99 | CSK | 0.36800814 |
| 100 | TYK2 | 0.36427235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.04067632 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.03175090 |
| 3 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.00152353 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.75545524 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.45846074 |
| 6 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.36358294 |
| 7 | Phototransduction_Homo sapiens_hsa04744 | 2.32406193 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.27640570 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23522953 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.22133139 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16290124 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.00025686 |
| 13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.88977436 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.76219044 |
| 15 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.72711282 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70432523 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70029190 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.67651942 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66670368 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.60483517 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58473561 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51541490 |
| 23 | Mineral absorption_Homo sapiens_hsa04978 | 1.49450727 |
| 24 | Protein export_Homo sapiens_hsa03060 | 1.46601719 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45204039 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38724763 |
| 27 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.37506058 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34078906 |
| 29 | Taste transduction_Homo sapiens_hsa04742 | 1.32998110 |
| 30 | Ribosome_Homo sapiens_hsa03010 | 1.30710207 |
| 31 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28779044 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25714987 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22851499 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21907737 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20768606 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17776612 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14895563 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.13318085 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12181819 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11116288 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.04254901 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.01899521 |
| 43 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01825283 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 1.00299419 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99850517 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.97905475 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96555383 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93261050 |
| 49 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92998500 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.92703580 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.92483523 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90793261 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.90115176 |
| 54 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.88082121 |
| 55 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87801669 |
| 56 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85846933 |
| 57 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83257165 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 0.81449551 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.80007207 |
| 60 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77788268 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74902647 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72437296 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72049225 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71515042 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 0.71469615 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71369885 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.68052312 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67806466 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.66370784 |
| 70 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65726549 |
| 71 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64646773 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64112168 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.63653243 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.63608751 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.63594666 |
| 76 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63533052 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62827949 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.58935775 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.58750219 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58357183 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58229930 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55672294 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.53939210 |
| 84 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49510511 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.47565811 |
| 86 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46070520 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.46050820 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45135122 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44304562 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43446623 |
| 91 | Insulin secretion_Homo sapiens_hsa04911 | 0.42499909 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42217759 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41801756 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41557122 |
| 95 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39820826 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.39456725 |
| 97 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38217738 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.37415607 |
| 99 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36802664 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.35121908 |

